- Ifosfamide in the pediatric malignant solid tumors
-
Choi SW
- KMID: 1691329
- J Korean Pediatr Soc.
- 1992 Mar;35(3):371-380.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical effect of ifosfamide based regimens for the management of recurrent or persistent gynecologic malignancy
-
Kim KS, Kim KT, Cho SH, Yoo JB, Hwang YY, Moon H, Lee JU
- KMID: 1694368
- J Korean Cancer Assoc.
- 1993 Oct;25(5):687-695.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Cisplatin, Ifosfamide . Paclitaxel (CIP) as Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Carcinoma
-
Yoon SB, Lee JK, Jeon S, Lee JY, Choi SD, Bae DH
- KMID: 1569622
- Korean J Obstet Gynecol.
- 2000 Oct;43(10):1763-1768.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Ifosfamide-Based Regimen in Refractory of Relapsed Ovarian Cancer
-
Lee HP, Park NH, Kim JW, Park SY, Song YS, Kang SB
- KMID: 1890522
- Korean J Gynecol Oncol Colposc.
- 1996 Dec;7(4):263-269.
This phase II study aimed to assess the clinical activity and toxicity of ifosfamide based regimen in patients with epithelial ovarian cancer, relapsed or refractory to cisplatin-containing combination chemotherapy. From... -
- CITED
-
- Close
- SHARE
-
- Close
- Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases
-
Shin YJ, Kim JY, Moon JW, You RM, Park JY, Nam JH
- KMID: 2167570
- Cancer Res Treat.
- 2011 Dec;43(4):260-263.
Central nervous system (CNS) toxicity has been reported in approximately 10-30% of patients receiving intravenous infusions of ifosfamide. Encephalopathy is a rare but serious CNS adverse reaction in these patients,... -
- CITED
-
- Close
- SHARE
-
- Close
- Ifosfamide-induced Fanconi syndrome with diabetes insipidus
-
Leem AY, Kim HS, Yoo BW, Kang BD, Kim MH, Rha SY, Kim HS
- KMID: 1792043
- Korean J Intern Med.
- 2014 Mar;29(2):246-249.
- doi: 10.3904/kjim.2014.29.2.246
Ifosfamide-induced Fanconi syndrome is a rare complication that typically occurs in young patients due to a cumulative dose of ifosfamide > 40-60 g/m2, a reduction in kidney mass, or concurrent... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase I Clinical Trial of Paclitaxel Plus Ifosfamide for the Patients with Refractory Ovarian Cancer
-
Saw HS, Lee JK
- KMID: 1815306
- J Korean Cancer Assoc.
- 2000 Oct;32(5):895-903.
PURPOSE: Patients with advanced ovarian carcinoma and refractory to platinum based chemotherapy have a very poor prognosis and effective salvage regimens are needed. This study was conducted in order to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Neoadjuvant PI(Cisplatin, Ifosfamide) and PAIB(Cisplatin, Adriamycin, Ifosfamide, Bleomycin) in the Cervical Cancer
-
Kim JH, Weon JY, Jeon CS, You BJ, Lee YS, Park IS
- KMID: 2245050
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):23-28.
For cervical cancer, the combination chemotherapy could increase the trial of radical hysterectomy due to reduction in tumor volume even in advanced stage and help to decrease corrected dose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Selective Proximal Tubule Injury and Progressive Renal Failure due to Ifosfamide and Cisplatin in a Patient with Ovarian Cancer
-
Kim SH, Nam SM, Yoon HE, Kim YK, Park EY, Kim WY, Kim YS
- KMID: 2253238
- Korean J Nephrol.
- 2008 Jul;27(4):513-517.
Ifosfamide-induced nephrotoxicity is usually manifested in the form of Fanconi syndrome and the combination of cisplatin enhances ifosfamide-induced nephrotoxicity. We here report a case of report specific proximal tubular dysfunction... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Malignant Glomus Tumor on Shoulder with Pulmonary Metastasis Treated with Doxorubicin and Ifosfamide in a 10-year Old Girl
-
Jin WS, Jeon IS
- KMID: 2168912
- Clin Pediatr Hematol Oncol.
- 2016 Apr;23(1):65-69.
- doi: 10.15264/cpho.2016.23.1.65
Malignant glomus tumor is an exceedingly rare neoplasm occurring in the soft tissues. Controversy exists over whether malignant glomus tumor is a true malignancy due to the rarity of metastasis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
-
Kim YI, Yoon JY, Hwang JE, Shim HJ, Bae WK, Cho SH, Chung IJ
- KMID: 2165959
- Cancer Res Treat.
- 2010 Dec;42(4):244-246.
The alkylating agent ifosfamide is an anti-neoplastic used to treat various pediatric and adult malignancies. Its potential urologic toxicities include glomerulopathy, tubulopathy and hemorrhagic cystitis. This report describes a case... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Ifosfamide, Etoposide and Cisplatin(IEP) Chemotherapy for Advanced Non-Small Cell Lung Cancer
-
Lee SN
- KMID: 1965085
- Ewha Med J.
- 1993 Dec;16(4):337-340.
- doi: 10.12771/emj.1993.16.4.337
To evaluste the efficacy and toxicity of IEP chemotherapy in locally advanced and metastatic non-small cell lung cancer, nineteen previously untreated patients with non-small cell lung cancer were studied. Patients received... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination chemotherapy with vinorelbine and ifosfamide for advanced non-small cell lung cancer
-
Cho EK, Hong SH, Bang SM, Lee HK, Park JW, Jeong SH, Nam G, Shin DB, Lee JH
- KMID: 1600623
- Korean J Med.
- 2001 Jan;60(1):70-76.
BACKGROUND: Although cisplatin (CDDP)-based chemotherapy is currently considered to be the most active treatment for advanced non-small cell lung cancer (NSCLC), ultimate prognosis still remains poor. More effective cytotoxic agents... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy with Vinorelbine and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer
-
Kim SG, Kim SH, Kwon HC, Lee KH, Kim JS, Kim HJ
- KMID: 2174991
- J Korean Cancer Assoc.
- 2001 Apr;33(2):163-167.
PURPOSE: We conducted a phase II study of vinorelbine and ifosfamide combination chemotherapy in patients with advanced or recurrent non-small cell lung cancer (NSCLC) to evaluate response rate, response duration,... -
- CITED
-
- Close
- SHARE
-
- Close
- Ifosfamide and Etoposide in Relapsed Refractory Childhood Acute Lymphoblastic Leukemia
-
Kim SS, Cho B, Jeong DC, Kim HK
- KMID: 2072458
- Korean J Pediatr Hematol Oncol.
- 1997 Apr;4(1):90-97.
BACKGROUND: The prognosis for children with relapsed acute lymphoblastic leukemia remains dismal. Ifosfamide has previously been shown to be active as a single agent and in combination with doxorubicin, etoposide,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Combination Chemotherapy with Ifosfamide Cisplatin, and Etoposide(ICE) in Advanced Non-Small Cell Lung Cancer
-
Lee G, Kim BD, Kang HJ, Lee SW, Oh HA, Bae SH, Lee JL, Lee KH, Hyun MS, Shin KC, Jung JH, Lee KH, Ryu HM
- KMID: 2318363
- Tuberc Respir Dis.
- 2002 Apr;52(4):309-316.
BACKGROUND: To evaluate the efficacy and toxicity of combination chemotherapy using ifosfamide, cisplatin, and etoposide in patients with advanced non-small cell lung cancer(NSCLC). MATERIALS AND METHODS: Thirty-three patients with inoperable... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pediatric Solid Pseudopapillary Tumor of the Pancreas Treated with Gemcitabine
-
Shim YJ, Kang JH, Lee KS
- KMID: 2168938
- Clin Pediatr Hematol Oncol.
- 2011 Apr;18(1):66-69.
Solid pseudopapillary tumors of the pancreas (SPTPs) are rare tumors with limited malignant potential; they are mainly diagnosed in young women. Complete surgical resection of the tumor is usually possible... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy with Cisplatin , Etoposide , and Ifosfamide ( PIE ) in the Advanced Non - Small Cell Lung Cancer
-
Shin SW, Kim BS, Shin JJ, Kim YH, Kang KH, Choi YH, Kim KT, Kim JS
- KMID: 2329112
- J Korean Cancer Assoc.
- 1998 Apr;30(2):225-230.
PURPOSE: Combination chemotherapy with cisplatin and etoposide have been considered as one of the chemotherpy regimen for non small cell lung cacer(NSCLC) with the response rate of 20~40%. Ifosfamide is... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Combination Chemotherapy with Vinorelbine, Carboplatin, and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer
-
Lee YW, Ryoo BY, Kim TY, Kim BS, Park YH, Hong HJ, Kwag JY, Lee SW, Kang YK
- KMID: 2175134
- J Korean Cancer Assoc.
- 1999 Dec;31(6):1227-1235.
PURPOSE: Despite recent advances in chemotherapy, the treatment outcome of advanced non-small cell lung cancer (NSCLC) remains poor and NSCLC is still the predominant source of cancer-related mortality in worldwide.... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy of Advanced Soft Tissue Sarcoma with Etoposide, Ifosfamide, and Cisplatin (VIP)
-
Kim WS, Jung KH, Kim HA, Yang SH, Heo DS, Bang YJ, Kim NK
- KMID: 1531929
- J Korean Cancer Assoc.
- 1997 Feb;29(1):128-135.
PURPOSE: Soft tissue sarcomas are uncommon primary malignancies. So studies on the effective chemotherapy for soft tissue sarcomas are limited. We started this study to evaluate the effectiveness of VIP... -
- CITED
-
- Close
- SHARE
-
- Close
